SHORT REPORT

Immunohistochemical assays in prostatic biopsies processed in Bouin’s fixative

V Ananthanarayanan¹, M R Pins², R E Meyer³ and P H Gann^1,4

¹ The Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
² The Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611
³ The Pathology Core Facility, Northwestern University Feinberg School of Medicine
⁴ Department of Preventive Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA

Correspondence to:
Correspondence to:
Dr V Ananthanarayanan
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, 680 North Lake Shore Drive, Suite1102, Chicago, IL 60611, USA; viju{at}northwestern.edu

Aims: To investigate the problems involved in undertaking immunohistochemistry (IHC) and nuclear morphometry using Bouin’s fixed prostate biopsies.

Methods: Archival Bouin’s fixed and formalin fixed, paraffin wax embedded prostatic biopsies were immunostained for three nuclear biomarkers (minichromosome maintenance protein 2 (MCM-2), p27, and Ki-67), one membrane localised biomarker (C-erb-B2), CD34, and  methylacyl-CoA racemase (AMACR). The quality of IHC staining was compared between tissues prepared separately in both fixatives. Feulgen staining was also performed on Bouin’s fixed tissues to check its suitability for nuclear morphometry.

Results: MCM-2 staining was completely negative in Bouin’s fixed tissues, whereas p27 showed more background and excess cytoplasmic staining in Bouin’s fixed versus formalin fixed tissues. C-erb-B2 showed non-specific, strong luminal cell staining in the Bouin’s fixed tissue. Feulgen staining was also very weak in Bouin’s fixed tissue. However, Ki-67, AMACR, and CD34 worked equally well in Bouin’s and formalin fixed tissues.

Conclusions: Bouin’s fixed tissues may be unsuitable when subsequent IHC and morphometry are contemplated. An awareness of which antibodies are suitable for use in Bouin’s fixed biopsies is essential.

Abbreviations: AMACR, methylacyl-CoA racemase; BF, Bouin’s fixed; IHC, immunohistochemistry; MCM-2, minichromosome maintenance protein 2; NBF, neutral buffered formalin

Keywords: Bouin’s fixative; immunohistochemistry; prostate

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Berney, D M (2008). Staging and classification of testicular tumours: pitfalls from macroscopy to diagnosis. J. Clin. Pathol. 61: 20-24 [Abstract] [Full Text]  
• Brinkman-Van der Linden, E. C M, Hurtado-Ziola, N., Hayakawa, T., Wiggleton, L., Benirschke, K., Varki, A., Varki, N. (2007). Human-specific expression of Siglec-6 in the placenta. Glycobiology 17: 922-931 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Dangers of Bouin's Fixation.

Daniel M Berney

JCP Online, 1 Sep 2005 [Full text]

Re: Dangers of Bouin's Fixation.

Vijayalakshmi Ananthanarayanan, et al.

JCP Online, 14 Nov 2005 [Full text]